TNF and inflammatory bowel disease: A study by Ratnakumaran et al.10 examined the efficacy and tolerability of CT-P13 treatment in 69 patients with IBD compared with 53 anti-TNF treatment-naïve patients who started with the infliximab originator and were monitored for 12 months.